Institutional investors purchased a net $1.1 million shares of NWBO during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 14.64% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.1 Million shares of Northwest Biotherapeutics...
SSGA FUNDS MANAGEMENT, INC. Bought 315.3 Thousand shares of Northwest Biotherapeutics...